Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Archives of Neurology|October 12, 2011
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological SurveillanceR Philip Kinkel, Mariya Dontchev, Craig Kollman, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 1, 2019
Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009?Sarah L Minden, R Philip Kinkel, Helene T Machado, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 30, 2014
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosisAudrey P Fan, Sindhuja T Govindarajan, R Philip Kinkel, et al.The New England Journal of Medicine|September 11, 2009
Asymptomatic reactivation of JC virus in patients treated with natalizumabYiping Chen, Evelyn Bord, Troy Tompkins, et al.Annals of Neurology|April 2, 2014
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosisSpyridon Chalkias, Xin Dang, Evelyn Bord, et al.Annals of Neurology|March 29, 2002
Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analysesRoy W Beck, Danielle L Chandler, Stephen R Cole, et al.Neurology|January 27, 2006
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating eventR Philip Kinkel, Craig Kollman, Paul O'Connor, et al.Pageof 2